Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-75
SponsorTri-Service General Hospital
About this trial
This study aims to investigate the combined use of corticosteroid injections and ESWT for SIJ pain.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Low back pain lasting for 3 months or more
Pain VAS score of 4 or higher
Three or more positive results in sacroiliac joint provocation tests
At least 50% pain relief following ultrasound-guided sacroiliac joint injection with local anesthetic
Disqualifiers
Currently undergoing extracorporeal shockwave therapy in other areas
Suspected pain caused by other lumbar spine or hip joint conditions (e.g., lumbar spine or disc disorders, radicular pain, spondylolisthesis/disc degeneration, hip arthritis)
Presence of complex comorbidities, including trauma, systemic infections (e.g., fever, chills, night sweats), local sacroiliac joint infections, autoimmune diseases, or immunosuppression
Sacroiliac joint injection therapy received within the past 6 months
Trial design
Design model
Parallel
Treatments tested in this trial
Corticosteroids Triamcinolone Acetonide
Drugultrasound-guided sacroiliac joint corticosteroid injections (1 ml SHINCORT INJ 10 MG/ML + 1 ml 2% Xylocaine)
extracorporeal shockwave
Devicea three-week course of weekly extracorporeal shockwave therapy sessions (intensity: low to moderate, adjusted based on patient tolerance; frequency: 5 Hz; 2000 shocks per session)
extracorporeal shockwave(minimum intensity)
Devicea three-week course of weekly extracorporeal shockwave therapy sessions (intensity: minimum setting on the device; frequency: 5 Hz; 2000 shocks per session)
Treatment groups
44 Participants
are divided into 2 treatment groupsGroup A: Corticosteroid Injection and shockwave TherapyExperimental treatment 2 interventions
Group B: Corticosteroid Injection and sham shockwave TherapySham comparator 2 interventions
Trial outcomes
Primary outcomes
1
pain Visual Analogue Scale(VAS)
The visual analogue scale (VAS) is a scale used to determine the pain intensity experienced by individuals. "0" means painless and "10" means extremely painful.
Time frame
baseline, one week after treatment, and at 1, 3, and 6 months post-treatmentSecondary outcomes
1
Oswestry Disability Index, ODI
The Oswestry Disability Index (ODI) was used to assess the degree of functional impairment caused by low back pain. The index consists of 10 items, each with 6 options scored from 0 to 5, representing varying levels of disability. A score of 0 indicates no disability, while a score of 5 indicates severe disability. The scores for all items are summed to obtain a total score, with a maximum possible score of 50, which is then expressed as a percentage.
Time frame
baseline, one week after treatment, and at 1, 3, and 6 months post-treatment2
Quantitative scintigraphy of the sacroiliac joints
Quantitative scintigraphy of the sacroiliac joints is an imaging technique used to evaluate the sacroiliac joint, commonly employed to diagnose joint issues such as inflammation, joint lesions, or other pathological conditions causing pain. During the scanning process, a radiolabeled substance is typically injected into the body, which accumulates in areas of high bone activity, particularly those with inflammation or injury. This highlights metabolic activity or structural changes within the joint.
Time frame
baseline, 3 months post-treatmentLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: